$LUCD
Lucid Diagnostics Inc.

2022 Q3 Form 10-Q Financial Statement

#000149315222023043 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $76.00K $189.0K
YoY Change -62.0%
Cost Of Revenue $1.626M $369.0K
YoY Change 1027.05%
Gross Profit $76.00K -$180.0K
YoY Change 36.37%
Gross Profit Margin 100.0% -95.24%
Selling, General & Admin $9.590M $11.18M $9.209M
YoY Change 119.17% 139700.0%
% of Gross Profit 12618.42%
Research & Development $2.704M $3.440M $2.881M
YoY Change 23.48% 83.66%
% of Gross Profit 3557.89%
Depreciation & Amortization $593.0K $704.0K $24.00K
YoY Change 134672.73% 23366.67%
% of Gross Profit 780.26%
Operating Expenses $14.43M $14.62M $12.09M
YoY Change 119.71% 143.09%
Operating Profit -$14.35M -$14.62M -$12.27M
YoY Change 120.42% 143.09%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $1.000K
YoY Change
Pretax Income -$14.35M -$14.62M -$12.27M
YoY Change 106.26% 137.29%
Income Tax
% Of Pretax Income
Net Earnings -$14.35M -$14.62M -$12.27M
YoY Change 106.26% 137.29%
Net Earnings / Revenue -18880.26% -6492.06%
Basic Earnings Per Share -$0.39 -$0.41 -$0.35
Diluted Earnings Per Share -$394.1K -$408.9K -$344.6K
COMMON SHARES
Basic Shares Outstanding 38.57M shares 35.76M shares 35.12M shares
Diluted Shares Outstanding 36.41M shares 35.76M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.93M $32.68M $47.92M
YoY Change 126113.68% 1364.66%
Cash & Equivalents $26.93M $32.68M $47.92M
Short-Term Investments
Other Short-Term Assets $2.882M $3.196M $4.324M
YoY Change 26.23% 73.32%
Inventory
Prepaid Expenses
Receivables $31.00K $89.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.85M $35.88M $52.33M
YoY Change 1091.73% 780.34%
LONG-TERM ASSETS
Property, Plant & Equipment $1.499M $1.266M $3.319M
YoY Change
Goodwill
YoY Change
Intangibles $3.950M $4.456M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.078M $1.724M $695.0K
YoY Change 36.14% 126.16%
Total Long-Term Assets $8.529M $9.526M $9.728M
YoY Change 977.15% 1149.64%
TOTAL ASSETS
Total Short-Term Assets $29.85M $35.88M $52.33M
Total Long-Term Assets $8.529M $9.526M $9.728M
Total Assets $38.38M $45.40M $62.06M
YoY Change 1064.21% 838.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.102M $2.406M $4.462M
YoY Change -61.2% 56.23%
Accrued Expenses $1.988M $2.043M $2.995M
YoY Change 19780.0% 818.0%
Deferred Revenue
YoY Change
Short-Term Debt $6.610M $2.429M $1.770M
YoY Change -70.49% -89.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.700M $7.878M $14.11M
YoY Change -64.64% -68.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.143M $1.282M $1.455M
YoY Change
Total Long-Term Liabilities $1.143M $1.282M $1.455M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.700M $7.878M $14.11M
Total Long-Term Liabilities $1.143M $1.282M $1.455M
Total Liabilities $10.84M $9.160M $15.57M
YoY Change -60.47% -63.05%
SHAREHOLDERS EQUITY
Retained Earnings -$83.15M -$68.80M
YoY Change
Common Stock $37.00K $36.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.53M $36.24M $46.49M
YoY Change
Total Liabilities & Shareholders Equity $38.38M $45.40M $62.06M
YoY Change 1064.21% 838.54%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$14.35M -$14.62M -$12.27M
YoY Change 106.26% 137.29%
Depreciation, Depletion And Amortization $593.0K $704.0K $24.00K
YoY Change 134672.73% 23366.67%
Cash From Operating Activities -$6.346M -$13.31M -$5.776M
YoY Change 190.8% 137.22%
INVESTING ACTIVITIES
Capital Expenditures -$321.0K -$236.0K -$148.0K
YoY Change 1063.89% 2189.04%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$2.200M
YoY Change
Cash From Investing Activities -$1.321M -$2.436M -$148.0K
YoY Change 4689.7% 23527.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.922M 501.0K 187.0K
YoY Change -93.53%
NET CHANGE
Cash From Operating Activities -6.346M -13.31M -5.776M
Cash From Investing Activities -1.321M -2.436M -148.0K
Cash From Financing Activities 1.922M 501.0K 187.0K
Net Change In Cash -5.745M -15.24M -5.737M
YoY Change 159.98% -818.9%
FREE CASH FLOW
Cash From Operating Activities -$6.346M -$13.31M -$5.776M
Capital Expenditures -$321.0K -$236.0K -$148.0K
Free Cash Flow -$6.025M -$13.07M -$5.628M
YoY Change 179.63% 133.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001799011
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2021Q4 LUCD Purchase Consideration Payable Current
PurchaseConsiderationPayableCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2021Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
usd
us-gaap Interest Expense Debt
InterestExpenseDebt
usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
shares
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
shares
LUCD Issuance Of Common Stock Installment Settlement Payment
IssuanceOfCommonStockInstallmentSettlementPayment
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
dei Document Type
DocumentType
10-Q
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
LUCD Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
usd
LUCD Rightofuse Assets Obtained In Exchange For New Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
usd
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40901
dei Entity Registrant Name
EntityRegistrantName
LUCID DIAGNOSTICS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5488042
dei Entity Address Address Line1
EntityAddressAddressLine1
One Grand Central Place
dei Entity Address Address Line2
EntityAddressAddressLine2
60 E. 42nd Street
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 4600
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10165
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10165
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
949-4319
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
LUCD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38568462 shares
CY2022Q2 us-gaap Cash
Cash
32679000 usd
CY2021Q4 us-gaap Cash
Cash
53656000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
200000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3196000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3447000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
35875000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
57303000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1266000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
971000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2080000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4456000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1724000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
725000 usd
CY2022Q2 us-gaap Assets
Assets
45401000 usd
CY2021Q4 us-gaap Assets
Assets
58999000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2406000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1490000 usd
CY2022Q2 LUCD Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
1245000 usd
CY2021Q4 LUCD Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
1113000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
798000 usd
CY2022Q2 LUCD Purchase Consideration Payable Current
PurchaseConsiderationPayableCurrent
1000000 usd
CY2022Q2 LUCD Msa Fee Operating Expenses And Interest Expense
MSAFeeOperatingExpensesAndInterestExpense
2429000 usd
CY2021Q4 LUCD Msa Fee Operating Expenses And Interest Expense
MSAFeeOperatingExpensesAndInterestExpense
1657000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7878000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4260000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1282000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1282000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
9160000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4260000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35994667 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35994667 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34917907 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34917907 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
35000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
105003000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96608000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68798000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41904000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
36241000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54739000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45401000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58999000 usd
us-gaap Revenues
Revenues
189000 usd
us-gaap Cost Of Revenue
CostOfRevenue
369000 usd
us-gaap Gross Profit
GrossProfit
-180000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3873000 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1021000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7191000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1710000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7311000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3122000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13202000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4334000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3440000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1873000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6321000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3625000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
14624000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6016000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-26894000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9669000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
6016000 usd
us-gaap Operating Expenses
OperatingExpenses
26714000 usd
us-gaap Operating Expenses
OperatingExpenses
9669000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14624000 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
147000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
147000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-147000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-147000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14624000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6163000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26894000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9816000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14624000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6163000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26894000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9816000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35760492 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14114707 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35443526 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14114707 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
46491000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
502000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3553000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
290000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
210000 usd
CY2022Q2 LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments Shares
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPaymentsShares
117371000 usd
CY2022Q2 LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments
239000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14624000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
36241000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54739000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
688000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7091000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
588000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
210000 usd
LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments Shares
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPaymentsShares
117371000 usd
LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments
239000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26894000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
36241000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16366000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2526000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
53000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6163000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-13518000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3328000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
56000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9816000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-19950000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26894000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-19950000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9816000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
728000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
LUCD Stockbased Compensation Expense Lucid Diagnostics Inc
StockbasedCompensationExpenseLucidDiagnosticsInc
7091000 usd
LUCD Stockbased Compensation Expense Lucid Diagnostics Inc
StockbasedCompensationExpenseLucidDiagnosticsInc
3328000 usd
LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
588000 usd
LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
56000 usd
LUCD Issuance Of Common Stock Installment Settlement Payment
IssuanceOfCommonStockInstallmentSettlementPayment
239000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-200000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
748000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
515000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
916000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-517000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
132000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-26000 usd
LUCD Increase Decrease In Operating Expenses
IncreaseDecreaseInOperatingExpenses
-1333000 usd
LUCD Increase Decrease In Operating Expenses
IncreaseDecreaseInOperatingExpenses
1731000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
147000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19081000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5609000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
384000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2584000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
688000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7739000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
688000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7739000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20977000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2120000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53656000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
111000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32679000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2231000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zJtHPfiQYr4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpTVzuh6HiIl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.13in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent losses, as of the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these (unaudited) condensed consolidated financial statements include those related to the estimated fair value of stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 — Summary of Significant Accounting Policies</b> - continued</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Accounting Policies</b> - Continued</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Cost Of Revenue
CostOfRevenue
369000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7311000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3122000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13202000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4334000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3440000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1873000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6321000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3625000 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
543000 usd
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
439000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
882000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
549000 usd
CY2022Q2 LUCD Floor Price Per Share
FloorPricePerShare
0.70
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14000 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
1657000 usd
LUCD Msa Fees
MsaFees
2340000 usd
LUCD On Behalf Of Obo Activities
OnBehalfOfOboActivities
646000 usd
LUCD Erc Payroll Benefits
ErcPayrollBenefits
4459000 usd
LUCD Cap Nostics Transfer
CapNosticsTransfer
2105000 usd
LUCD Cash Payments
CashPayments
-8778000 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
2429000 usd
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
2100000 usd
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
2100000 usd
LUCD Royalty Percentage
RoyaltyPercentage
0.05 pure
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000000 usd
LUCD Royalty Percentage On Annual Sales
RoyaltyPercentageOnAnnualSales
0.080 pure
LUCD Cost Of Goods And Services Sold Annualy
CostOfGoodsAndServicesSoldAnnualy
100000000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3196000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3447000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
463000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
927000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
883000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2281000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
201000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2080000 usd
LUCD Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
453000 usd
LUCD Rightofuse Assets Obtained In Exchange For New Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
2448000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M23D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07875 pure
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2080000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2080000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
798000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1282000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5305000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-849000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4456000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
639000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1010000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2021000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
688000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
421000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
316000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4456000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1419242 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.73
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2107500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.82
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
959389 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
107687 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.45
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2459666 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.22
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
741869 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.90
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3843000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2580000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7679000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3384000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.71 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030 pure
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35994667 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35994667 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34917907 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34917907 shares
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
50000000 usd
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
1000000.0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-14624000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6163000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26894000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9816000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35760492 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14114707 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35443526 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14114707 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4720406 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2951342 shares

Files In Submission

Name View Source Status
0001493152-22-023043-index-headers.html Edgar Link pending
0001493152-22-023043-index.html Edgar Link pending
0001493152-22-023043.txt Edgar Link pending
0001493152-22-023043-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lucd-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
lucd-20220630_lab.xml Edgar Link unprocessable
lucd-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
lucd-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lucd-20220630_def.xml Edgar Link unprocessable